CellCentric's Grant - II Round

CellCentric raised a round of funding on May 10, 2010. Investors include Biotechnology and Biological Sciences Research Council.

CellCentric is a clinical stage biotechnology company focused on the development of the novel drug CCS1477 for prostate (CRPC) and other cancers.…

Articles about CellCentric's Grant - II Round: